Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3Mucosolvan
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2019 Revenue in Millions : 108
2018 Revenue in Millions : 120
Growth (%) : -10
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2020 Revenue in Millions : 104
2019 Revenue in Millions : 120
Growth (%) : -13
Main Therapeutic Indication : Respiratory Disorders
Currency : USD
2018 Revenue in Millions : 124
2017 Revenue in Millions : 141
Growth (%) : -12%
LOOKING FOR A SUPPLIER?